Sfoglia per AUTORE
CAPELLETTO E
Collezione AOU San Luigi di Orbassano

  

Items : 24

The evolving landscape of stage III unresectable non-small cell lung cancer "between lights and shadows". in Cancer treatment reviews / Cancer Treat Rev. 2025 Mar 11;135:102918. doi: 10.1016/j.ctrv.2025.102918.
2025
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ricardi U; Levis M; Capelletto E; Bironzo P; Merlini A; Reale ML; Ungaro A; Cani M; Garbo E; Napoli VM; Mogavero A; Saba G; Crespi V; Delcuratolo MD; Novello S; Passiglia F;

Niraparib plus Dostarlimab in Pleural Mesothelioma or Non-Small Cell Lung Cancer Harboring HRR Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2024 Mar 1;30(5):959-964. doi: 10.1158/1078-0432.CCR-23-2431.
2024
AOU San Luigi di Orbassano

Passiglia F; Righi L; Bironzo P; Listì A; Farinea G; Capelletto E; Novello S; Merlini A; Scagliotti GV;

A case series of non-small cell lung cancer patients with EGFR or HER2 exon 20 insertion in Li Fraumeni syndrome. in Tumori / Tumori. 2024 Dec;110(6):NP5-NP10. doi: 10.1177/03008916241255485. Epub 2024 May 23.
2024
AOU San Luigi di Orbassano

Cognigni V; Capelletto E; Bordi P; Pavese V; Carfì FM; Gelsomino F; De Giglio A; Chiari R; Minari R; Ambrosini E; Percesepe A; Giachino D; Bironzo P; Tiseo M;

Exploring the Potential of Non-Coding RNAs as Liquid Biopsy Biomarkers for Lung Cancer Screening: A Literature Review. in Cancers / Cancers (Basel). 2023 Sep 28;15(19):4774. doi: 10.3390/cancers15194774.
2023
AOU San Luigi di Orbassano

Garbo E; Del Rio B; Ferrari G; Cani M; Napoli VM; Bertaglia V; Capelletto E; Rolfo C; Novello S; Passiglia F;

How Does Environmental and Occupational Exposure Contribute to Carcinogenesis in Genitourinary and Lung Cancers? in Cancers / Cancers (Basel). 2023 May 19;15(10):2836. doi: 10.3390/cancers15102836.
2023
AOU San Luigi di Orbassano

Cani M; Turco F; Butticè S; Vogl UM; Buttigliero C; Novello S; Capelletto E;

Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®). in Tumori / Tumori. 2023 Jun;109(3):324-334. doi: 10.1177/03008916221099558. Epub 2022 Jun 8.
2023
AOU San Luigi di Orbassano

Caminiti C; Bryce J; Riva S; Ng D; Diodati F; Iezzi E; Sparavigna L; Novello S; Porta C; Del Mastro L; Procopio G; Cinieri S; Falzetta A; Calabrò F; Lorusso V; Cogoni AA; Tortora G; Maruzzo M; Passalacqua R; Cognetti F; Adamo V; Capelletto E; Ferrari A; Bagnalasta M; Bassi M; Nicelli A; De Persis D; D'Acunti A; Iannelli Patient E; et alii...

2023
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Passiglia F; Novello S; Gianetta M; Di Maio M; D'Amiano C; Capelletto E; Bianco V; Bertaglia V; Napoli VM; Leone G; Cecchi C; Audisio A; Turco F; Delcuratolo MD; Cetoretta V; Pisano C; Parlagreco E; Garbo E; Ferrari G; Del Rio B; Cani M; Persano I; Scagliotti GV; Bironzo P;

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Sangiolo D; Righi L; Passiglia F; Di Maio M; Paratore C; Bungaro M; De Filippis M; Consito L; Mecca C; Bertaglia V; Carnio S; Capelletto E; Listì A; Reale ML; Rezmives NA; Tesauro M; Indellicati D; Tabbò F; Mariniello A; Novello S; Geuna M; Bironzo P;

A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Apr;172:103639. doi: 10.1016/j.critrevonc.2022.103639. Epub 2022 Feb 19
2022
ASL Asti
AOU San Luigi di Orbassano

Passiglia F; Novello S; Buffoni L; Carnio S; Capelletto E; Zichi C; Reale ML; Artusio E; Olmetto E; Bungaro M; Paratore C; Bertaglia V; Audisio M; Rapetti SG; Pignataro D; Curcio H; De Luca E; Bironzo P; Tagliamento M; Scagliotti GV; Di Maio M;

Immune-checkpoint inhibition in stage III unresectable NSCLC: Challenges and opportunities in the post-PACIFIC era. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2021 Jul;157:85-91. doi: 10.1016/j.lungcan.2021.05.009. Epub 2021 May 11.
2021
AOU San Luigi di Orbassano

Passiglia F; Leone G; Olmetto E; Delcuratolo MD; Tabbò F; Reale ML; Bertaglia V; Consito L; Bironzo P; Capelletto E; Novello S;

Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Jan;157:103189. doi: 10.1016/j.critrevonc.2020.103189. Epub 2020 Nov 27
2021
AOU San Luigi di Orbassano

Sperone P; Capelletto E; Artusio E; Carnio S; Di Stefano RF; Rapetti S; Audisio M; Bungaro M; Tabbò F; Leone G; Mariniello A; Palesandro E; Bironzo P; Reale ML; Bertaglia V; Passiglia F; Novello S;

Major breakthroughs in lung cancer adjuvant treatment: Looking beyond the horizon. in Cancer treatment reviews / Cancer Treat Rev. 2021 Dec;101:102308. doi: 10.1016/j.ctrv.2021.102308. Epub 2021 Oct 18.
2021
AOU San Luigi di Orbassano

Passiglia F; Bertaglia V; Reale ML; Delcuratolo MD; Tabbò F; Olmetto E; Capelletto E; Bironzo P; Novello S;

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Novello S; Di Maio M; Passiglia F; Capelletto E; Boccuzzi A; Caramello V; Olmetto E; Persano I; De Filippis M; Pisano C; Bironzo P; Mariniello A;

Improving lung cancer outcomes through smoking cessation: the Women Against Lung Cancer in Europe (WALCE) experience. in Journal of thoracic disease / J Thorac Dis. 2020 Jul;12(7):3877-3882. doi: 10.21037/jtd.2020.03.76.
2020
AOU San Luigi di Orbassano

Capelletto E; Passiglia F; Ferraresi F; Vallone S; Novello S;

Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2019 Aug;134:210-217. doi: 10.1016/j.lungcan.2019.06.028. Epub 2019 Jun 27.
2019
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Migliaretti G; Pacchiana MV; Critelli R; Manzo A; Metro G; Morelli AM; Ricciardi S; Bria E; Colantonio I; Ciuffreda L; Del Conte A; Ceresoli GL; Pisconti S; Scotti V; Gregorc V; Romano G; Galetta D; Delmonte A; Tiseo M; Costanzo FD; Chiari R; Grossi F; Stura I; Morabito A; Migliorino MR; Capelletto E; Novello S;

Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach. in PloS one / PLoS One. 2019 Nov 13;14(11):e0224027. doi: 10.1371/journal.pone.0224027. eCollection 2019.
2019
AOU San Luigi di Orbassano

Bruni A; Giaj-Levra N; Ciammella P; Maragna V; Ferrari K; Bonti V; Grossi F; Greco S; Greco C; Borghetti P; Franceschini D; Capelletto E; Perna M; Banna G; Vagge S; Baldini E; Bria E; Botti A; Tiseo M; Paci M; Taraborrelli M; Poletti V; Granone P; Ricardi U; Novello S; Scotti V;

NGR-hTNF and Doxorubicin as Second-Line Treatment of Patients with Small Cell Lung Cancer. in The oncologist / Oncologist. 2018 Oct;23(10):1133-e112. doi: 10.1634/theoncologist.2018-0292. Epub 2018 Aug 3.
2018
AOU San Luigi di Orbassano

Gregorc V; Cavina R; Novello S; Grossi F; Lazzari C; Capelletto E; Genova C; Salini G; Lambiase A; Santoro A;

Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2018 Nov;13(11):1750-1761. doi: 10.1016/j.jtho.2018.07.002. Epub 2018 Jul 7.
2018
AOU San Luigi di Orbassano

Pelosi G; Papotti M; Righi L; Rossi G; Ferrero S; Bosari S; Calabrese F; Kern I; Maisonneuve P; Sonzogni A; Albini A; Harari S; Barbieri F; Capelletto E; Catino AM; Cavone D; De Palma A; Fusco N; Lunardi F; Maiorano E; Marzullo A; Novello S; Papanikolaou N; Pasello G; Pennella A; Pezzuto F; Punzi A; Prisciandaro E; Rea F; et alii...

Loss of C/EBP-? LIP drives cisplatin resistance in malignant pleural mesothelioma. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2018 Jun;120:34-45. doi: 10.1016/j.lungcan.2018.03.022. Epub 2018 Mar 26.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Rubinstein M; Novello S; Di Maio M; Napoli F; Pradotto M; Capelletto E; Ricci L; Ananthanarayanan P; Milosevic V; Grosso F; Libener R; Orecchia S; Salaroglio IC; Righi L; Kopecka J; Scagliotti GV; Riganti C;

Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer. in Future oncology (London, England) / Future Oncol. 2018 Feb;14(4):353-361. doi: 10.2217/fon-2017-0441. Epub 2017 Nov 14.
2018
AOU San Luigi di Orbassano

Metro G; Passaro A; Lo Russo G; Bonanno L; Giusti R; Gregorc V; Capelletto E; Martelli O; Cecere FL; Giannarelli D; Luciani A; Bearz A; Tuzi A; Scotti V; Tonini G; Galetta D; Carta A; Soto Parra H; Rebonato A; Morabito A; Chiari R; Metro G; Passaro A; Lo Russo G; Bonanno L; Giusti R; Gregorc V; Capelletto E; Martelli O; et alii...

Impact of non-small-cell lung cancer-not otherwise specified immunophenotyping on treatment outcome. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2014 Oct;9(10):1540-6. doi: 10.1097/JTO.0000000000000271.
2014
AOU San Luigi di Orbassano

Righi L; Vavalà T; Rapa I; Vatrano S; Giorcelli J; Rossi G; Capelletto E; Novello S; Scagliotti GV; Papotti M;

First-line therapeutic options for advanced non-small-cell lung cancer in the molecular medicine era. in Future oncology (London, England) / Future Oncol. 2014 May;10(6):1081-93. doi: 10.2217/fon.13.247.
2014
AOU San Luigi di Orbassano

Capelletto E; Novello S; Scagliotti GV;

2014
AOU San Luigi di Orbassano

Novello S; Capelletto E; Cortinovis D; Tiseo M; Galetta D; Valmadre G; Casartelli C; Rapetti SG; Rossi A;

Emerging new agents for the management of patients with non-small cell lung cancer. in Drugs / Drugs. 2012 Jun 19;72 Suppl 1:37-52. doi: 10.2165/1163028-S0-000000000-00000.
2012
AOU San Luigi di Orbassano

Capelletto E; Novello S;